> The study found that povidone iodine "may reduce the carriage of infectious SARS-CoV-2 in adults with mild to moderate COVID-19"—but that means it was found t

> The study found that povidone iodine "may reduce the carriage of infectious SARS-CoV-2 in adults with mild to moderate COVID-19"—but that means it was found to only reduce the amount of virus in a person's nose when they're already infected with COVID-19. That certainly sounds like a positive, unless you think viral load doesn't matter? Based on the study from your article, it seems that a careful few day course of this treatment after known exposure could help prevent significant infection. At the very least warrants further study. The cons in that article make the assumptions people will swallow it and then some non-sequitur about deterring vaccination. Not a great argument, doc.